Quality Control Scientist, Controls

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.

The Quality Control Scientist, Controls will lead the development, qualification, and lifecycle management of analytical control materials used in QC assays. This role will be responsible for generating and maintaining positive and negative controls, designing and executing analytical studies, and troubleshooting and optimizing analytical methods used in QC testing. 

 

Ph.D. in Biological Sciences, Biochemistry, Molecular Biology, Bioengineering, or a related discipline.

Strong background in primary cell culture and analytical assay development, troubleshooting, and experimental design.

Hands-on experience with analytical techniques such as ELISA, PCR/qPCR, flow cytometry, or other biochemical or cell-based assays.

Experience designing and executing analytical studies and interpreting experimental data.

Strong understanding of assay controls, assay performance monitoring, and analytical method lifecycle management.

Strong written and verbal communication skills with the ability to clearly summarize complex scientific findings.

Ability to work independently and manage multiple scientific projects in a fast-paced environment.